Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.

Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page
- Check3 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a consolidated 'Locations' section listing participating states and a revision tag (v3.3.3). Removed individual state location pages (Arizona Locations, California Locations, etc.) and the HHS Vulnerability Disclosure.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedNew notes clarify that publications are voluntarily provided by the study submitter and may be auto-filled from PubMed, with some items potentially not directly about the study. The revision tag has been updated to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page no longer displays the government funding status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedThe two screenshots show the same Study Details page (NCT01627249) with no noticeable changes to content or layout.SummaryDifference0.2%

- Check91 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference2%

- Check98 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no substantive changes to content or important data.SummaryDifference0.0%

Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.